News
Hosted on MSN3m
UK Watchdogs Fine 23andMe $3.1M for Data Security ViolationsA bid from Regeneron Pharmaceuticals to buy most of the company's assets for $256 million was met with criticism, but that ...
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results